NASDAQ$LFST
LifeStance Health Group Inc · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
LifeStance Health reported Q3 2025, revenue of $363.8M, net income of $1.1M.
LifeStance generated third quarter 2025 revenue of 356800000, representing solid year-over-year growth driven by higher visit volumes and clinician expansion. Net income was 6200000 and Adjusted EBITDA reached 42000000, reflecting continued operating leverage and margin improvement.
- Revenue increased year-over-year to 356800000 driven by volume growth.
- Visit volumes grew to 2300000 supported by clinician expansion.
- Net income improved to 6200000 compared to prior-year loss.
- Adjusted EBITDA increased to 42000000 reflecting operating leverage.
Headline financials
Revenue & EPS history
LifeStance · Revenue · Quarterly
$357M
Forward guidance
The company reaffirmed full year 2025 guidance, expecting continued revenue growth, Center Margin expansion, and Adjusted EBITDA improvement supported by clinician productivity and visit growth.
Tailwinds
- Sustained double-digit revenue growth.
- Continued clinician base expansion.
- Improving operating leverage.
- Rising Center Margin year-over-year.
- Strong Adjusted EBITDA growth trajectory.
Headwinds
- Exposure to reimbursement rate pressures.
- Dependence on clinician recruitment and retention.
- Ongoing interest expense impact.
- Regulatory and healthcare compliance risks.
- Macroeconomic factors could affect patient demand.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
-4.5%
Avg return
Earnings day
+0.3%
Avg return
5 days after
+1.2%
Avg return
30 days after
42%
8 / 19 earnings
Positive
+24.6%
Q4 2023
Best reaction
-49.7%
Q2 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +19.8% | +7.7% | +0.5% | |
| Q4 2025 | +4.3% | +0.0% | -11.5% | |
| Q3 2025 | -3.6% | +29.1% | +30.1% | |
| Q1 2025 | -16.0% | -10.7% | -10.8% | |
| Q4 2024 | +3.1% | +6.8% | -10.8% | |
| Q3 2024 | +3.2% | +3.8% | +2.9% | |
| Q2 2024 | +1.6% | +6.0% | +26.1% | |
| Q1 2024 | -1.7% | +5.9% | -19.1% | |
| Q4 2023 | +24.6% | +21.8% | -3.4% | |
| Q3 2023 | -9.4% | -8.9% | +7.9% | |
| Q2 2023 | -5.0% | -7.4% | -17.1% | |
| Q1 2023 | -1.4% | +1.1% | +1.7% | |
| Q4 2022 | +22.2% | +23.8% | +65.6% | |
| Q3 2022 | -30.4% | -15.9% | -23.0% | |
| Q2 2022 | +6.2% | +10.8% | +29.3% | |
| Q1 2022 | -13.9% | +0.4% | +10.1% | |
| Q4 2021 | -12.7% | -5.9% | +4.2% | |
| Q3 2021 | -27.3% | -22.8% | -29.1% | |
| Q2 2021 | -49.7% | -40.6% | -30.2% | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro